We are ambitious. We are curious. We are pioneers.
At Alector we are forging a new path for overcoming the tremendous burden caused by neurodegenerative diseases and cancer. Our approach centers on mining the human genome to identify mutations in immune system genes that increase the risk for these disorders. From there, we are innovating new drugs that counteract the damage these mutations cause.
Alector is a privately-owned biotechnology based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery.
Alector Address
131 Oyster Point Blvd South San Francisco, CA United States